FDA Clears ArtVentive’s 11 mm Endoluminal Occlusion System

The FDA has granted ArtVentive Medical Group 510(k) clearance to market its 11 mm Endoluminal Occlusion System.

The catheter-based, self-expandable device is designed for use in the peripheral vasculature, and offers immediate and complete vessel occlusion of veins and arteries, according to the Carlsbad, Calif., company.

The 11 mm EOS joins ArtVenture’s 3 mm version, allowing interventional radiologists “to treat larger vessels with precision and reliability,” says President Leon Rudakov. — Michael Cipriano